Related Experiment Video

Updated: Oct 9, 2026

DNA-FISH Metaphase Spreads to Distinguish Extrachromosomal DNA from Homogeneously Staining Regions in Human Cancer Cell Lines
08:21

DNA-FISH Metaphase Spreads to Distinguish Extrachromosomal DNA from Homogeneously Staining Regions in Human Cancer Cell Lines

Published on: August 4, 2026

Genomic organization and chromosomal mapping of SPARC-like 1, a gene down regulated in cancers

S G Isler1, S Schenk, I Bendik

  • 1Laboratory of Molecular Oncology, Department of Research, University Hospital Basle, CH-4031 Basle, Switzerland.

International Journal of Oncology
|February 17, 2001
PubMed

Insights

Human SPARCL1 gene, implicated in lung, prostate, and colon cancers, has been cloned and mapped. Its genomic structure and promoter region were analyzed to understand its role in tumor formation.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • Human SPARC-like 1 (SPARCL1), also known as MAST9 or hevin, is part of the SPARC protein family.
  • SPARCL1 is frequently downregulated in non-small cell lung cancer (NSCLC), prostate, and colon carcinomas, suggesting a role in tumorigenesis.
  • Tumorigenesis often involves the inactivation of tumor suppressor genes, making SPARCL1 a potential candidate.

Purpose of the Study:

  • To clone and map the genomic locus of the human SPARCL1 gene.
  • To analyze the intron/exon organization and the 5'-flanking promoter region of SPARCL1.
  • To lay the groundwork for investigating SPARCL1's role in cancer through deletion/mutation analysis and transcriptional regulation studies.

Main Methods:

  • Fluorescence in situ hybridization (FISH) for gene localization.
  • Genomic DNA analysis to determine intron/exon structure.
  • DNA sequencing of the 5'-flanking region to identify the promoter.

Main Results:

  • The human SPARCL1 gene was successfully cloned and mapped to chromosome 4q22-25, a region frequently deleted in cancers.
  • SPARCL1 exhibits an 11-exon, 10-intron structure spanning approximately 47 kb, similar to its murine homologue.
  • The 2.4 kb 5'-flanking region, containing the putative promoter, was sequenced.

Conclusions:

  • The genomic locus and structure of the human SPARCL1 gene have been elucidated.
  • This foundational data is essential for future studies on SPARCL1 deletions and mutations in various cancers.
  • Understanding SPARCL1's promoter region will enable investigations into its transcriptional regulation and functional significance in tumor development.

More Related Videos

Genome-Wide Mapping of Histone Modifications and Transcription Factor Binding Sites in Neuroendocrine Small Cell Lung Cancer Cell Lines Using CUT&RUN11:50

Genome-Wide Mapping of Histone Modifications and Transcription Factor Binding Sites in Neuroendocrine Small Cell Lung Cancer Cell Lines Using CUT&RUN

Published on: April 3, 2026

Related Concept Videos

Chromatin Position Affects Gene Expression02:35

Chromatin Position Affects Gene Expression

Chromatin is the massive complex of DNA and proteins packaged inside the nucleus. The complexity of chromatin folding and how it is packaged inside the nucleus greatly influences  access to genetic information. Generally, the nucleus' periphery is considered transcriptionally repressive, while the cell's interior is considered a transcriptionally active area. 
Topologically Associated Domains (TADs)
The 3-dimensional positioning of chromatin in the nucleus influences the timing and level of...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...